A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease

NCT02265276 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

Fatty Liver

Interventions

DRUG: Saroglitazar
DRUG: Pioglitazone

Sponsor

Command Hospital, India